Related content

The Use of Molecular Markers in Farnesyltransferase Inhibitor (FTI) Therapy of Breast Cancer

By Moasser M.M.  

Breast Cancer Research and Treatment, Vol. 73, Iss. 2, 2002-05 ,pp. : 135-144

Springer Publishing Company

Access to resources Recommend Favorite

Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels

By          

International Journal of Oncology, Vol. 41, Iss. 2, 2012-01 ,pp. : 629-638

Spandidos Publications

Access to resources Recommend Favorite

Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome

By Witzel Isabell   Milde-Langosch Karin   Wirtz Ralph   Roth Claudia   Ihnen Maike   Mahner Sven   Zu Eulenburg Christine   Jänicke Fritz   Müller Volkmar  

Journal of Cancer Research and Clinical Oncology, Vol. 136, Iss. 11, 2010-11 ,pp. : 1709-1718

Springer Publishing Company

Access to resources Recommend Favorite

Distinct Molecular Signature of Inflammatory Breast Cancer by cDNA Microarray Analysis

By Laere Steven  

Breast Cancer Research and Treatment, Vol. 93, Iss. 3, 2005-10 ,pp. : 237-246

Springer Publishing Company

Access to resources Recommend Favorite

Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis

By Cassone Marco  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 217-218

Informa Healthcare

Access to resources Recommend Favorite